Aptose Biosciences APTO

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.14 (+4.75%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Aptose Biosciences (APTO)
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $3.17

  • Market Cap

    $6.79 Million

  • Price-Earnings Ratio

    -0.01

  • Total Outstanding Shares

    2.14 Million Shares

  • Total Employees

    36

  • Dividend

    No dividend

  • IPO Date

    July 30, 1992

  • SIC Description

    Biological Products, (no Disgnostic Substances)

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    66 wellington street west, suite 5300, Toronto, A6, M5K 1E6

  • Homepage

    https://www.aptose.com

Historical Stock Splits

If you bought 5,400 shares of APTO before October 6, 2014, you'd have 1 share today.
Execution DateSplit Amount
February 26, 20251-for-30 (Reverse Split)
June 6, 20231-for-15 (Reverse Split)
October 6, 20141-for-12 (Reverse Split)

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow, Continuing$-7.39 Million
Net Cash Flow From Financing Activities, Continuing$27.46 Million
Net Cash Flow$-7.39 Million
Net Cash Flow From Operating Activities$-37.18 Million
Net Cash Flow From Financing Activities$27.46 Million
Net Cash Flow From Operating Activities, Continuing$-37.18 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Nonoperating Income/Loss$397,000
Revenues$0
Basic Earnings Per Share$-3.05
Preferred Stock Dividends And Other Adjustments$0
Net Income/Loss Attributable To Parent$-35.80 Million
Other Operating Expenses$15.01 Million

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss$-35.80 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss Attributable To Parent$-35.80 Million
Other Comprehensive Income/Loss$-23.84 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Liabilities And Equity$10.93 Million
Assets$10.93 Million
Equity$-9.13 Million
Fixed Assets$30,000
Current Assets$10.23 Million
Other Current Liabilities$7.05 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about APTO from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.